Medpace Holdings, Inc.·4

Oct 29, 4:58 PM ET

EWALD STEPHEN P 4

4 · Medpace Holdings, Inc. · Filed Oct 29, 2025

Insider Transaction Report

Form 4
Period: 2025-10-27
EWALD STEPHEN P
General Counsel & Corp. Secy.
Transactions
  • Sale

    Common Stock

    2025-10-27$598.85/sh15,230$9,120,48613,343 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-10-2718,2300 total
    Exercise: $166.73Exp: 2026-10-27Common Stock (18,230 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-27$166.73/sh+18,230$3,039,48828,573 total
Footnotes (2)
  • [F1]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $596.25 to $602.955. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
  • [F2]The option vested in full on October 27, 2025.

Documents

1 file
  • 4
    wk-form4_1761771495.xmlPrimary

    FORM 4